These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24389105)

  • 1. Cirrhosis development probably arises from chronic micro-vascular ischemia.
    Mancuso A
    Med Hypotheses; 2014 Feb; 82(2):244. PubMed ID: 24389105
    [No Abstract]   [Full Text] [Related]  

  • 2. The ischemic liver cirrhosis theory and its clinical implications.
    Mancuso A
    Med Hypotheses; 2016 Sep; 94():4-6. PubMed ID: 27515188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies.
    Kage M; Shimamatu K; Nakashima E; Kojiro M; Inoue O; Yano M
    Hepatology; 1997 Apr; 25(4):1028-31. PubMed ID: 9096615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF)].
    Takashima T; Iijma H; Nishiguchi S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():145-9. PubMed ID: 26845920
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver biopsy assessment in chronic hepatitis.
    Lefkowitch JH
    Arch Med Res; 2007 Aug; 38(6):634-43. PubMed ID: 17613355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of chronically-diseased liver to prolonged hemihepatic ischemia during hepatectomy.
    Kim YI; Ishii T; Kitano S; Morimoto A; Nakashima K; Kamada N; Sugimachi K
    Int Surg; 1995; 80(2):108-10. PubMed ID: 8530222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of endothelial dysfunction in progression of liver fibrosis and manifestation of сryoglobulinemia syndrome in patients with chronic hepatitis C].
    Riabokon' IuIu
    Georgian Med News; 2013; (220-221):34-8. PubMed ID: 24013148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric assessment of nucleolar activity in liver cells during the evolutive pathway of chronic hepatitis C to cirrhosis.
    Betta PG; Robutti F; Fruttaldo L; Pavesi M; Pastormerlo M; Tallarida F
    Pathologica; 1993; 85(1095):31-6. PubMed ID: 8516024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).
    Wanless IR; Liu JJ; Butany J
    Hepatology; 1995 May; 21(5):1232-7. PubMed ID: 7737628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal blood velocity and portal blood flow in patients with chronic viral hepatitis: relation to histological liver fibrosis.
    Koda M; Murawaki Y; Kawasaki H; Ikawa S
    Hepatogastroenterology; 1996; 43(7):199-202. PubMed ID: 8682462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract]   [Full Text] [Related]  

  • 13. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis].
    Garbuzenko DV
    Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A young woman with cirrhosis: autoimmune hepatitis vs. alpha 1-antitrypsin deficiency.
    Lok AS; Ghany MG; Gerber MA
    Hepatology; 1994 May; 19(5):1302-6. PubMed ID: 8175155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications for drug therapy of chronic active hepatitis and posthepatitis liver cirrhosis].
    Strohmeyer G; Lübke HJ
    Dtsch Med Wochenschr; 1985 Jan; 110(3):104-5. PubMed ID: 3967586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathophysiology of hepatic fibrosis].
    Vaĺková M
    Vnitr Lek; 2002 Jan; 48(1):27-33. PubMed ID: 11852583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 62-year-old woman with chronic diarrhea, hepatic fibrosis and interstitial lymphoid pneumonitis].
    Sánchez-Guerrero J; Baquera J; Alessio LP
    Rev Invest Clin; 1987; 39(3):291-7. PubMed ID: 3432769
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
    Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of liver fibrosis in patients with chronic hepatitis B].
    Shi J; Hao JH; Ren WH; Zhu JR; Wang SY; Xie YB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):443-5. PubMed ID: 19567024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic viral hepatitis C. Anatomoclinical and biological correlations].
    Loria A; Giral P; Serfaty L; Guéchot J; Legendre C; Poupon R
    Gastroenterol Clin Biol; 1995 May; 19(5):508-13. PubMed ID: 7590003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.